These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 23732163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE, Os I, Mahfoud F.
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renal denervation: a plea for wisdom.
    Lantelme P, Courand PY, Pathak A.
    Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
    [No Abstract] [Full Text] [Related]

  • 6. The "resistant hypertension team": focus on a multidisciplinary approach to hypertension.
    Potthoff SA, Rump LC, Vonend O.
    EuroIntervention; 2013 May; 9 Suppl R():R48-53. PubMed ID: 23732155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka PA, Cremers B, Böhm M.
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [Abstract] [Full Text] [Related]

  • 11. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Charting new frontiers in interventional medicine.
    Fajadet J.
    EuroIntervention; 2013 May; 9 Suppl R():R10-1. PubMed ID: 23732138
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Late renal artery stenosis after percutaneous renal denervation.
    Lambert T, Blessberger H, Grund M, Steinwender C.
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e169-e170. PubMed ID: 25090272
    [Abstract] [Full Text] [Related]

  • 16. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ.
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
    Schlaich MP.
    Am J Hypertens; 2017 Sep 01; 30(9):847-856. PubMed ID: 28338871
    [Abstract] [Full Text] [Related]

  • 19. Response and non-response to renal denervation: who is the ideal candidate?
    Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F.
    EuroIntervention; 2013 May 01; 9 Suppl R():R54-7. PubMed ID: 23732156
    [Abstract] [Full Text] [Related]

  • 20. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 01; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.